Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RAB5A |
| Upstream (Parents) |
|---|
| (<<) ADAM17 → RAB5A |
| (<<) CASP8 → RAB5A |
| (<<) CREB1 → RAB5A |
| (<<) DHX9 → RAB5A |
| (<<) MAPK14 → RAB5A |
| (<<) PIK3CB → RAB5A |
| (<<) PRPF4B → RAB5A |
| Downstream (Children) |
|---|
| RAB5A → ATP2B4 (>>) |
| RAB5A → CPD (>>) |
| RAB5A → CRKL (>>) |
| RAB5A → EML4 (>>) |
| RAB5A → EWSR1 (>>) |
| RAB5A → GNA13 (>>) |
| RAB5A → GNAQ (>>) |
| RAB5A → HMGCS1 (>>) |
| RAB5A → ITCH (>>) |
| RAB5A → MAP3K2 (>>) |
| RAB5A → MAPK1 (>>) |
| RAB5A → MCL1 (>>) |
| RAB5A → PTGER4 (>>) |
| RAB5A → RB1 (>>) |
| RAB5A → THBS1 (>>) |
| RAB5A → TXNIP (>>) |
